Companies / Turkey
Turkish Drug Reimbursement Stokes Multinationals' Ire
April 2006 | Company Finance AlertA recent study by a Turkish research consultancy has called for the country to mirror the success of the Ireland's health service and implement a number of regulatory reforms. The report, which was undertaken on behalf of Turkey's Association of Research-Based Pharmaceutical Companies, claims that the Turkey's regulatory system in unclear and inconsistent, especially in areas such as reimbursement and marketing authorisations.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
